Finally, as RUNX1 mutations are found in 32% of sporadic AML (23, 24), translational studies might be relevant for clarifying leukemogenesis in familial platelet disorders (FDP) (23, 24). The gene discussed is RUNX1; the disease is acute myeloid leukemia.